» Articles » PMID: 31427387

Peptide Growth Factors and Their Receptors in the Vein Wall

Overview
Journal J Investig Med
Publisher Sage Publications
Specialty General Medicine
Date 2019 Aug 21
PMID 31427387
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

The varicose vein wall remodeling is a very complex process, which is controlled by numerous factors, including peptide growth factors. The aim of the study was to assess a/b FGF, IGF-1, TGF-β1, VEGF-A and their receptors in the vein wall. Varicose vein samples were taken from 24 patients undergoing varicose vein surgery. The control material consisted of vein specimens collected from 12 patients with chronic limb ischemia. Contents of aFGF, bFGF, IGF-I, TGF-β1, VEGF, IGF-1R, VEGF R1 and VEGF R2 were assessed with ELISA method. Protein expression of FGF R1 and TGF-β RII were evaluated with western blot. Increased contents of aFGF, IGF-1 and VEGF-A were found in varicose veins in comparison with normal ones (p<0.05). In contrast, a significant decrease in TGF-β content was demonstrated in varicose veins (p<0.05). Furthermore, there was no difference in bFGF content in both groups (p>0.05). IGF-1 R content was significantly increased in varicose veins (p<0.05). There was no difference in VEGF R1 content between varicose and normal veins (p>0.05), whereas VEGF R2 content was significantly increased in varicose veins (p<0.05). Western blot demonstrated increased expression of TGF-β RII in varicose veins (p<0.05) and similar expression of FGF R1 in both groups (p>0.05). Demonstrated changes in peptide growth factors and their receptors may disturb metabolism of extracellular matrix in the varicose vein wall and contribute to the development of the disease to its more advanced stages.

Citing Articles

Innovative Approaches and Future Directions in the Management and Understanding of Varicose Veins: A Systematic Review.

Javaid A, Ka A, Pm S, Arora K, Mudavath S ACS Pharmacol Transl Sci. 2024; 7(10):2971-2986.

PMID: 39421653 PMC: 11480891. DOI: 10.1021/acsptsci.4c00430.


Venous Wall of Patients with Chronic Venous Disease Exhibits a Glycolytic Phenotype.

Fraile-Martinez O, Garcia-Montero C, Alvarez-Mon M, Gomez-Lahoz A, Monserrat J, Llavero-Valero M J Pers Med. 2022; 12(10).

PMID: 36294781 PMC: 9604927. DOI: 10.3390/jpm12101642.


[Research advances on the role of acid fibroblast growth factor in promotion of wound healing].

Wang H, Han J, Hu D Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi. 2022; 38(9):859-863.

PMID: 36177591 PMC: 11704672. DOI: 10.3760/cma.j.cn501120-20210811-00276.


Overexpression of glycolysis markers in placental tissue of pregnant women with chronic venous disease: a histological study.

Ortega M, Saez M, Fraile-Martinez O, Alvarez-Mon M, Garcia-Montero C, Guijarro L Int J Med Sci. 2022; 19(1):186-194.

PMID: 34975312 PMC: 8692115. DOI: 10.7150/ijms.65419.


Chronic venous disease patients show increased IRS-4 expression in the great saphenous vein wall.

Ortega M, Fraile-Martinez O, Garcia-Montero C, Ruiz-Grande F, Barrena S, Montoya H J Int Med Res. 2021; 49(9):3000605211041275.

PMID: 34590920 PMC: 8489764. DOI: 10.1177/03000605211041275.